(Q34802622)

4 August 2017

title

Developing urinary metabolomic signatures as early bladder cancer diagnostic markers (English)

1 reference

4 August 2017

1 reference

Chong Shen

1

1 reference

4 August 2017

Zeyu Sun

2

1 reference

4 August 2017

Deying Chen

3

1 reference

4 August 2017

Xiaoling Su

4

1 reference

4 August 2017

Jing Jiang

5

1 reference

4 August 2017

Gonghui Li

6

1 reference

4 August 2017

Biaoyang Lin

7

1 reference

4 August 2017

Jiajun Yan

8

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 January 2015

1 reference

OMICS A Journal of Integrative Biology

4 August 2017

published in

1 reference

4 August 2017

volume

19

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

1-11

1 reference

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281851

Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281851

8 July 2018

Cancer statistics, 2012

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281851

Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281851

Bladder cancer determination via two urinary metabolites: a biomarker pattern approach

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281851

Urine cytology and adjunct markers for detection and surveillance of bladder cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281851

Diagnosis of urothelial carcinoma from urine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281851

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281851

Biomarkers for detection and surveillance of bladder cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281851

Critical evaluation of urinary markers for bladder cancer detection and monitoring

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281851

Urinary markers in bladder cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281851

Recent development of IMP dehydrogenase inhibitors for the treatment of cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281851

Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281851

Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281851

Noninvasive urinary metabonomic diagnosis of human bladder cancer.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281851

Taurine - a possible fingerprint biomarker in non-muscle invasive bladder cancer: A pilot study by 1H NMR spectroscopy.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281851

Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281851

Analysis of pyrimidine synthesis "de novo" intermediates in urine and dried urine filter- paper strips with HPLC-electrospray tandem mass spectrometry

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4281851

Measurements of complement factor H-related protein (BTA-TRAK assay) and nuclear matrix protein (NMP22 assay)--useful diagnostic tools in the diagnosis of urinary bladder cancer?

26 October 2018

1 reference

PubMed

12 December 2020

Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

Metabolomics study on the biochemical profiles of odor elements in urine of human with bladder cancer

1 reference

PubMed

12 December 2020

Identifiers

DOI

10.1089/OMI.2014.0116

1 reference

4 August 2017

1 reference

4 August 2017

1 reference